Primary Record
C24:1 Sulfatide
- In stock
- 3,885 g
- Purity
- 99.5 %
- CAS
- 151057-28-2
Compound Identifiers & Properties
- CAS
- 151057-28-2
- PubChem CID
- 5459361
- SMILES
- CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)OS(=O)(=O)O)O)NC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC)O
- Canonical SMILES
- CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(=O)(=O)O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC
Names & Synonyms
- C24:1 Sulfatide
- sulfatide C24:1
- Sulfo galactosylceramide
- CIS-TETRACOSENOYL SULFATIDE
- LH5A9ZGN2U
- AC1NURH0
- RefChem:577429
- D0X4FY
- Epitope ID:139419
- CHEBI:41539
- 151057-28-2
- orb1692144
- SCHEMBL29368186
- C48H91NO11S
- DTXSID901106551
- N-Tetracosenoyl-(cis-15)-sulfatide
- AKOS040756334
- CID5459361
- DB04661
- (3'-sulfo)Galbeta-Cer(d18:1/24:1(15Z))
- (3'-sulfo)Galbeta-Cer(d18:1/24:1)
- HY-125726
- C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z))
- CS-0093426
- NS00073107
- J1.603.399E
- 3-O-Sulfogalactosylceramide (d18:1/24:1(15Z))
- 1-(3-O-sulfo-beta-D-galactosyl)-N-[(15Z)-tetracos-15-enoyl]sphingosine
- (15Z)-N-((1S,2R,3E)-2-HYDROXY-1-{[(3-O-SULFO-BETA-D-GALACTOPYRANOSYL)OXY]METHYL}HEPTADEC-3-ENYL)TETRACOS-15-ENAMIDE
- Q27095410
- [(2R,3S,4S,5R,6R)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2S,3R)-3-hydroxy-2-[[(Z)-tetracos-15-enoyl]amino]octadec-4-enoxy]oxan-4-yl] hydrogen sulfate
- Cis-tetracosenoyl sulfatide (amyotrophic lateral sclerosis)
- C24:1 mono-sulfo galactosyl(beta) ceramide (d18:1/24:1)
- CIS
- N-[(1S)-2R-hydroxy-1-[[(3-O-sulfo-beta-D-galactopyranosyl)oxy]methyl]-3E-heptadecen-1-yl]-15Z-tetracosenamide
- 3-O-sulfo-D-galactosyl-beta1-1'-N-nervonoyl-D-erythro-sphingosine
- (15Z)-N-{(2S,3R,4E)-3-hydroxy-1-[(3-O-sulfo-beta-D-galactopyranosyl)oxy]octadec-4-en-2-yl}tetracos-15-enamide
- (2S,3R,4E)-N-NERVONIC-1-[BETA-D-(3-SULFATE)-GALACTOPYRANOSYL]-2-AMINO-OCTADECENE-3-OL
- [(2R,3R,4S,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-[(15Z)-tetracos-15-enamido]octadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid
- Cis-tetracosenoyl sulfatide (amyotrophic lateral sclerosis), Glycoregimmune
- 1-O-(3-O-Sulfo-beta-D-galactopyranosyl)-N-[(15Z)-1-oxo-15-tetracosenyl]sphingosine
- (15Z)-N-[(1S,2R,3E)-2-Hydroxy-1-[[(3-O-sulfo-beta-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-15-tetracosenamide
- (15Z)-N-[(1S,2R,3E)-2-Hydroxy-1-[[(3-O-sulfo-I(2)-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-15-tetracosenamide
- (15Z)-N-[(1S,2R,3E)-2-hydroxy-1-{[(3-O-sulfo-beta-D-galactopyranosyl)oxy]methyl}heptadec-3-en-1-yl]tetracos-15-enamide
- (2R,3R,4S,5S,6R)-3,5-Dihydroxy-2-(((2S,3R,E)-3-hydroxy-2-((Z)-tetracos-15-enamido)octadec-4-en-1-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl hydrogen sulfate
- (2S,3R,4E)-N-NERVONIC-1-[BETA-D-(3-SULFATE)-GALACTOPYRANOSYL]-2-AMINO-OCTADECENE-3-OL CIS-TETRACOSENOYL SULFATIDE
- [(2R,3S,4S,5R,6R)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2S,3R)-3-hydroxy-2-[[(Z)-tetracos-15-enoyl]amino]octadec-4-enoxy]tetrahydropyran-4-yl] hydrogen sulfate
- 15-Tetracosenamide, N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-beta-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-, (15Z)-
- N/A